Delivery Order SPE2DB24D2010-SPE2DB25FZYM7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $36,469.66 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $46,231.51 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed price, non-competitive delivery order was issued on April 24, 2025, with an ultimate completion date of April 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $38,088.74 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of June 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $13,832.89 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This is a firm fixed price delivery order issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was awarded competitively with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $31,940.40 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract supports the federal government's pharmaceutical procurement needs through AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $47,923.48 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors. The contract, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with a completion date of September 30, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $15,207.79 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors. The contract, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as a child delivery order under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,181.76 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a competitively awarded contract with no set-aside designation. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $42,049.66 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price procurement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FZYM7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $28,295.33 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, issued on May 8, 2025, with an ultimate completion date of May 9, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, medical devices, and specialty healthcare commodities. The Enbrel supply fulfills critical pharmaceutical needs within this broader DLA framework, supporting Defense Health Agency and other government healthcare system customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.3k | 5/8/25 |